Growth Inhibitory Property of Pentagamavunone-0 (PGV-0) on 4T1 Cells under Stress Condition : 2D and 3D Culture Model

Haruma Anggraini Muflikhasari, Riris Istighfari Jenie, Ratna Asmah Susidarti, Edy Meiyanto

Abstract


Pentagamavunone-0 (PGV-0), one of the curcumin analogue, is reported to have a cytotoxic effect on various cancer cells. This study aimed to explore the growth inhibitory effects of PGV-0 against highly-metastatic breast cancer, 4T1 cells under stress condition covering 2D and 3D speroid cytotoxic, anti-migration, and suppression of MMP-9. PGV-0 showed cytotoxic effects on 2D and 3D 4T1 cells with IC50value of 49 μM and 26 μM, respectively. In addition, PGV-0 performed anti-migratory effect. The single treatment at 25 μM PGV-0 and 50 μM showed inhibitory effect on cell migration by 54% and 51% respectively. whilst, the combination of PGV-0 at the concentration of 25 μM and 50 μM with doxorubicin significantly inhibited cell migration by 41% and 38%,  respectively. The gelatin zymography assay showed that PGV-0 decreased MMP-9 expression both in a single treatment and in combination with doxorubicin. In conclusion,  PGV-0 is potential to be developed as anti-tumorigenesis agent on highly-metastatic breast cancers.

Keywords: Pentagamavunone-0 (PGV-0), anti-migration, MMP-9, 4T1 cells, spheroid


Full Text:

PDF

References


Amalina, N.D., Nurhayati, I.P. and Meiyanto, E., 2017, Doxorubicin Induces Lamellipodia Formation and Cell Migration, Indones. J. Cancer Chemoprevention, 8, 61–67. CrossRef

Chen, G., Chen, Y., Yang, N., Zhu, X., Sun, L. and Li, G., 2012, Interaction between curcumin and mimetic biomembrane, Sci. China Life Sci., 55, 527–532. CrossRef

Courtneidge, S.A., 2012, Cell migration and invasion in human disease: the Tks adaptor proteins, Portland Press Limited.

Cui, X., Hartanto, Y. and Zhang, H., 2017. Advances in multicellular spheroids formation, J. R. Soc. Interface, 14. CrossRef

Glasauer, A., Chandel, N.S., 2014. Targeting antioxidants for cancer therapy, Biochem. Pharmacol, 92, 90–101. CrossRef

Grada, A., Otero-Vinas, M., Prieto-Castrillo, F., Obagi, Z., Falanga, V., 2017, Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay, J. Invest. Dermatol., 137, e11–e16. CrossRef

Hermawan, A., Fitriasari, A., Junedi, S., Ikawati, M., Haryanti, S., Widaryanti, B., Da’i, M. and Meiyanto, E., 2011, PGV-0 and PGV-1 Increased Apoptosis Induction of Doxorubicin on MCF-7 Breast Cancer Cells, Pharmacon, 12(2), 55-59.

Hu, X. and Beeton, C., 2010, Detection of functional matrix metalloproteinases by zymography, JoVE J. Vis. Exp., e2445.

Ikawati, M. and Septisetyani, E.P., 2018, Pentagamavunone-0 (PGV-0), a Curcumin Analog, Enhances Cytotoxicity of 5-Fluorouracil and Modulates Cell Cycle in WiDr Colon Cancer Cells, Indones. J. Cancer Chemoprevention, 9(1), 23-31. CrossRef

Kleiner Jr, D.E. and Stetler-Stevenson, W.G., 1993, Structural biochemistry and activation of matrix metalloproteases, Curr. Opin. Cell Biol., 5, 891–897.

Larasati, Y.A., Yoneda-Kato, N., Nakamae, I., Yokoyama, T., Meiyanto, E. and Kato, J., 2018, Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth, Sci. Rep., 8, 1–13. CrossRef

Meiyanto, E., Margono, S.A. and Da’i, M., 2003, Antiproliferative effect of PGV-0 (a curcumin analogue) against HeLa cells, Gama Sains, 5, 200–206.

Meiyanto, E., Putri, D.D.P., Susidarti, R.A., Murwanti, R., Sardjiman, S., Fitriasari, A., Husnaa, U., Purnomo, H. and Kawaichi, M., 2014, Curcumin and its Analogues (PGV-0 and PGV-1) Enhance Sensitivity of Resistant MCF-7 Cells to Doxorubicin through Inhibition of HER2 and NF-kB Activation, Asian Pac. J. Cancer Prev., 15, 179–184. CrossRef

Meiyanto, E., Putri, H., Larasati, Y.A., Utomo, R.Y., Jenie, R.I., Ikawati, M., Lestari, B., Yoneda-Kato, N., Nakamae, I. and Kawaichi, M., 2019, Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation, Advanced Pharmaceutical Bulletin, 9(3), 445-452.

Meiyanto, E., Septisetyani, E.P., Larasati, Y.A. and Kawaichi, M., 2018, Curcumin Analog Pentagamavunon-1 (PGV-1) Sensitizes Widr Cells to 5-Fluorouracil through Inhibition of NF-κB Activation, Asian Pac. J. Cancer Prev., 19(1), 49-56. CrossRef

Mosmann, T., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55–63.

Nunes, A.S., Barros, A.S., Costa, E.C., Moreira, A.F. and Correia, I.J., 2019, 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs: NUNES ET AL, Biotechnol. Bioeng., 116, 206–226. CrossRef

Putri, H., Jenie, R.I., Handayani, S., Kastian, R.F. and Meiyanto, E., 2016. Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells, Asian Pac J Cancer Prev., 17, 2683–2688.

Rötzer, V., Hartlieb, E., Winkler, J., Walter, E., Schlipp, A., Sardy, M., Spindler, V. and Waschke, J., 2016, Desmoglein 3-Dependent Signaling Regulates Keratinocyte Migration and Wound Healing, J. Invest. Dermatol., 136, 301–310. CrossRef

Yang, J., Guo, W., Wang, L., Yu, L., Mei, H., Fang, S., Chen, A., Liu, Y., Xia, K. and Liu, G., 2017, Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines, Oncol. Lett., 13, 2260–2268.

Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A. and Tesei, A., 2016, 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained, Sci. Rep., 6. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev10iss3pp149-158

Copyright (c) 2019 Haruma Anggraini Muflikhasari, Riris Istighfari Jenie, Ratna Asmah Susidarti, Edy Meiyanto

Indexed by:

               

               

      

 

Indonesian Society for Cancer Chemoprevention